Skip to main content

Rush University Selects BioFortis Software to Manage Methylation Biomarker Data


BioFortis said this week that investigators at Rush University Medical Center will use its Labmatrix database software to manage its biobank and biomarker data for research efforts focused on early detection and diagnosis of cancer and neurodegenerative diseases.

Specifically, the investigators will use Labmatrix to manage patient clinical information, patient biospecimens, operational biobanking workflows, and methylation biomarker research data in a centralized database system.

Furthermore, team members and collaborators can directly retrieve answers to complex questions about collected data from the system using a graphical visual query tool.

In a statement, Victor Levenson, a radiation oncologist at Rush, said the software will enable his team "to centrally track a wide range of scientific data" as well as "easily enter and get all of the relevant upstream and downstream information about disease areas, patients, biosamples, and biomarker profiles."

Last summer, the Catholic Health Initiatives’ Institutes for Research and Innovation’s Center for Translational Research deployed Labmatrix to support specimen biobanking, next-generation diagnostics, biomarker discovery, and translational research (BI 08/27/2010).

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.